Clinical Trial Detail

NCT ID NCT03833921
Title Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer (APRE)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Martha Mims
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: senior adult

No variant requirements are available.